BioMarin Pharmaceuticals Inc (BMRN) is a publicly traded Healthcare sector company. As of August 16, 2026, BMRN trades at $69.62 with a market cap of $13.04B and a P/E ratio of 183.22. BMRN moved -1.72% today. Year to date, BMRN is +13.34%; over the trailing twelve months it is +16.14%. Its 52-week range spans $49.26 to $73.51. Analyst consensus is strong buy with an average price target of $90.89. Rallies surfaces BMRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for BMRN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $69.62 |
| Market Cap | $13.04B |
| P/E Ratio | 183.22 |
| EPS | $0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $73.51 |
| 52-Week Low | $49.26 |
| Volume | 1.06M |
| Avg Volume | 0 |
| Revenue (TTM) | $3.41B |
| Net Income | $72.97M |
| Gross Margin | 76.12% |
19 analysts cover BMRN: 0 strong buy, 15 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $90.89.